Literature DB >> 19523575

The treatment of hyponatremia.

Richard H Sterns1, Sagar U Nigwekar, John Kevin Hix.   

Abstract

Virtually all investigators now agree that self-induced water intoxication, symptomatic hospital-acquired hyponatremia, and hyponatremia associated with intracranial pathology are true emergencies that demand prompt and definitive intervention with hypertonic saline. A 4- to 6-mmol/L increase in serum sodium concentration is adequate in the most seriously ill patients and this is best achieved with bolus infusions of 3% saline. Virtually all investigators now agree that overcorrection of hyponatremia (which we define as 10 mmol/L in 24 hours, 18 mmol/L in 48 hours, and 20 mmol/L in 72 hours) risks iatrogenic brain damage. Appropriate therapy should keep the patient safe from serious complications of hyponatremia while staying well clear of correction rates that risk iatrogenic injury. Accordingly, we suggest therapeutic goals of 6 to 8 mmol/L in 24 hours, 12 to 14 mmol/L in 48 hours, and 14 to 16 mmol/L in 72 hours. Inadvertent overcorrection owing to a water diuresis may complicate any form of therapy, including the newly available vasopressin antagonists. Frequent monitoring of the serum sodium concentration and urine output are mandatory. Administration of desmopressin to terminate an unwanted water diuresis is an effective strategy to avoid or reverse overcorrection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19523575     DOI: 10.1016/j.semnephrol.2009.03.002

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  59 in total

1.  [Language of the other].

Authors:  L von Ferber
Journal:  Fortschr Med       Date:  1975-12-04

Review 2.  Neurological counterparts of hyponatremia: pathological mechanisms and clinical manifestations.

Authors:  Manuel Alfredo Podestà; Irene Faravelli; David Cucchiari; Francesco Reggiani; Silvia Oldani; Carlo Fedeli; Giorgio Graziani
Journal:  Curr Neurol Neurosci Rep       Date:  2015-04       Impact factor: 5.081

3.  Minocycline prevents osmotic demyelination syndrome by inhibiting the activation of microglia.

Authors:  Haruyuki Suzuki; Yoshihisa Sugimura; Shintaro Iwama; Hiromi Suzuki; Ozaki Nobuaki; Hiroshi Nagasaki; Hiroshi Arima; Makoto Sawada; Yutaka Oiso
Journal:  J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 10.121

4.  Profound hyponatremia in cirrhosis: a case report.

Authors:  Aaron Lindsay
Journal:  Cases J       Date:  2010-03-23

5.  Challenges in the Management of a Patient with Myxoedema Coma in Ghana: A Case Report.

Authors:  Josephine Akpalu; Yacoba Atiase; Ernest Yorke; Henrietta Fiscian; Cecilia Kootin-Sanwu; Albert Akpalu
Journal:  Ghana Med J       Date:  2017-03

6.  Wide central pontine, bulbar and thalamic myelinolysis with sequela.

Authors:  Mustafa Uzkeser; Ayhan Akoz; Gokhan Ozdemir; Mucahit Emet; Atif Bayramoglu
Journal:  Eurasian J Med       Date:  2012-12

7.  Postoperative myxoedema coma.

Authors:  Robert James; Jessie James; Amarjit Singh Vij; Kamaljeet Kaur Vij
Journal:  BMJ Case Rep       Date:  2014-02-13

8.  A forgotten but important risk factor for severe hyponatremia: myxedema coma.

Authors:  Ayse Kargili; Faruk Hilmi Turgut; Feridun Karakurt; Benan Kasapoglu; Mehmet Kanbay; Ali Akcay
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

9.  Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the Emergency Department.

Authors:  Luigi Mario Castello; Marco Baldrighi; Alice Panizza; Ettore Bartoli; Gian Carlo Avanzi
Journal:  Intern Emerg Med       Date:  2016-07-21       Impact factor: 3.397

Review 10.  New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children.

Authors:  Michael L Moritz; Juan Carlos Ayus
Journal:  Pediatr Nephrol       Date:  2009-11-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.